1365970-47-3

Basic information

• Product Name: methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate
• Synonyms: methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate
• CAS NO: 1365970-47-3
• Molecular Formula: C30H36F2N4O7
• Molecular Weight: 602.63
• Mol File: 1365970-47-3.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 766.3±60.0 °C(Predicted)
• Appearance: /
• Density: 1.35±0.1 g/cm3(Predicted)
• PKA: 10.70±0.70(Predicted)
• CAS DataBase Reference: methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate(1365970-47-3)
• EPA Substance Registry System: methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate(1365970-47-3)

Safety Data

• Hazardous Substances Data: 1365970-47-3(Hazardous Substances Data)

Usage

Description

Methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate is a complex organic compound with a unique molecular structure. It is characterized by its fluorinated and carboxylated nature, which may contribute to its potential applications in various fields.

Uses

1. Used in Pharmaceutical Industry:
Methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate is used as an antiviral agent for its potential to combat viral infections. Its unique molecular structure may allow it to interact with viral proteins or enzymes, inhibiting their function and reducing the spread of the virus.
2. Used in Drug Synthesis:
Methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate is also used as an intermediate in the synthesis of Glecaprevir (1365970-03-1), a direct-acting antiviral medication used for the treatment of chronic hepatitis C virus (HCV) infection. Its role in the synthesis process is crucial for the development of effective treatments for HCV.